Speakers -------- N/A Cambridge Healthtech Instituteâ€™s second annual â€œOptimizing Biologics Formulation Development: Managing the Early Formulation-Manufacturing Interface to Overcome Stability, Processing and Manufacturing Challenges and Achieve Fit for Purpose Drug Productâ€� covers the latest trends and challenges in biologics formulation and development with a focus on: improving time to market via early formulations and characterization, overcoming aggregation challenges, utilizing enabling analytical methodologies, using experimental design and high-throughput principles, and improving convenience and compliance through delivery technologies. The conference features novel case studies, in-depth scientific presentations, and poster sessions. Time has been designated for interactive discussions with industry thought leaders during the BuzZ Sessions on Tuesday. It is part 1 of 3 within the â€œPipeline 1: Formulating Biologics: Meeting the Challengesâ€� track and is perfect for those new to the field, as well as those who require in-depth analysis of the latest trends, technologies, and techniques.
|Monday, January 11, 2010|
|Tuesday, January 12, 2010|